Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higuchi, Y.
Right arrow Articles by Yamaura, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higuchi, Y.
Right arrow Articles by Yamaura, A.
Related Collections
Right arrow All Oncology
Right arrow Primary brain tumor
Right arrow Chemotherapy-tumor
Right arrow Radiation therapy-tumor
Right arrow All Clinical trials
Right arrow Clinical trials Observational study (Cohort, Case control)
NEUROLOGY 2004;63:2384-2386
© 2004 American Academy of Neurology


Brief Communications

Treatment of low-grade oligodendroglial tumors without radiotherapy

Yoshinori Higuchi, MD, Yasuo Iwadate, MD and Akira Yamaura, MD

From the Department of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Address correspondence and reprint requests to Dr. Yasuo Iwadate, Department of Neurological Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba 260-8670, Japan; e-mail: iwadatey{at}faculty.chiba-u.jp

The authors prospectively treated 18 consecutive patients with low-grade oligodendroglial tumors without postoperative radiotherapy. The treatment strategy was as follows: follow-up after total resection and chemotherapy after subtotal resection or biopsy. All patients were alive and 17 patients (94%) were progression-free after a median follow-up of 4.7 years. The results suggested that radiotherapy could be postponed until clinical progression in the treatment of low-grade oligodendroglial tumors.


Received March 22, 2004. Accepted in final form August 2, 2004.




This article has been cited by other articles:


Home page
The OncologistHome page
J. T. Grier and T. Batchelor
Low-grade gliomas in adults.
Oncologist, June 1, 2006; 11(6): 681 - 693.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. U. Ty, S. J. See, J. P. Rao, J.B.K. Khoo, and M. C. Wong
Oligodendroglial tumor chemotherapy using "decreased-dose-intensity" PCV: A Singapore experience
Neurology, January 24, 2006; 66(2): 247 - 249.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.